Proteomics signs binding LOI with Sonic Healthcare USA
Filed with ASX · · 3 pages · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Clinical Utility Study demonstrates PromarkerD test benefits
- Potential breakthrough blood test for endometriosis
- June 2022 Quarterly Activities Report and Appendix 4C
- European PromarkerD patents expanded beyond diabetes
- Endometriosis clinical validation study readout positive
Later from Proteomics International Laboratories
- Proteomics raises $8m in highly successful Placement
- Completion of Placement and Exercise of Performance Rights
- OxiDx launched to maximise oxidative stress technology
- New Oesophageal Cancer Diagnostic shows strong performance
- Proteomics receives $1.7 million in R&D tax incentive
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories